Hervè Van De Poël

Title: Hervè Van De Poël: Innovator in P2X3 Inhibitors

Introduction

Hervè Van De Poël is a notable inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target specific receptors in the body.

Latest Patents

One of his key patents is titled "Amino quinazoline derivatives as P2X3 inhibitors." This invention relates to compounds that inhibit the P2X purinoceptor 3, specifically focusing on amino quinazoline derivatives. The patent outlines methods for preparing these compounds, pharmaceutical compositions that include them, and their therapeutic applications. These compounds may be beneficial in treating various disorders associated with P2X receptor mechanisms, such as respiratory diseases including cough, asthma, idiopathic pulmonary fibrosis (IPF), and chronic obstructive pulmonary disease (COPD). Hervè holds 1 patent in this area.

Career Highlights

Hervè Van De Poël is currently associated with Chiesi Farmaceutici S.p.a., a prominent pharmaceutical company. His work at Chiesi has allowed him to focus on innovative solutions for respiratory diseases, contributing to the advancement of medical treatments.

Collaborations

Throughout his career, Hervè has collaborated with esteemed colleagues such as Claudio Fiorelli and Paolo Bruno. These partnerships have fostered a collaborative environment that enhances research and development efforts in the pharmaceutical industry.

Conclusion

Hervè Van De Poël is a distinguished inventor whose work on P2X3 inhibitors has the potential to impact the treatment of various respiratory disorders. His contributions to the field of pharmaceuticals exemplify the importance of innovation in addressing complex health challenges.